HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EVOLUTION IN-VIVO TRACKED BY DNA HETERODUPLEX MOBILITY ASSAYS

被引:273
|
作者
DELWART, EL
SHEPPARD, HW
WALKER, BD
GOUDSMIT, J
MULLINS, JI
机构
[1] STANFORD UNIV,SCH MED,DEPT IMMUNOL & MICROBIOL,STANFORD,CA 94305
[2] CALIF DEPT HLTH SERV,VIRAL & RICKETTSIAL DIS LAB,BERKELEY,CA 94704
[3] MASSACHUSETTS GEN HOSP,INFECT DIS UNIT,BOSTON,MA 02114
[4] UNIV AMSTERDAM,ACAD MED CTR,HUMAN RETROVIRUS LAB,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1128/JVI.68.10.6672-6683.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
High mutation rates and strong selective pressures imposed on human immunodeficiency viruses in vivo result in the formation of pools of genetic variants known as quasispecies. DNA heteroduplex mobility and tracking analyses were used to monitor the generation of HIV sequence diversity, to estimate quasispecies complexity, and to assess the turnover of genetic variants to approach an understanding of the relationship between viral quasispecies evolution in vivo and disease progression. Proviral DNA pools were nearly homogeneous soon after sexual transmission. The emergence and clearance of individual variants then occurred at different rates in different individuals. High quasispecies complexity was found in long-term-infected, asymptomatic individuals, while rapid CD4(+) cell decline and AIDS were often, but not always, associated,vith lower quasispecies complexity. Proviral genetic variation was often low following in vitro culture, because of the outgrowth of one or a few variants that often became more abundant only later as proviruses in peripheral blood mononuclear cells. These studies provide insight into the dynamics of human immunodeficiency virus sequence changes in vivo and illustrate the utility of heteroduplex analysis for the study of phenomena associated with rapid genetic changes.
引用
收藏
页码:6672 / 6683
页数:12
相关论文
共 50 条
  • [1] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER INSERTION IN-VIVO
    RAINERI, I
    SOLER, M
    SENN, HP
    VIROLOGY, 1995, 208 (01) : 359 - 364
  • [2] REQUIREMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF FOR IN-VIVO REPLICATION AND PATHOGENICITY
    JAMIESON, BD
    ALDROVANDI, GM
    PLANELLES, V
    JOWETT, JBM
    GAO, LY
    BLOCH, LM
    CHEN, ISY
    ZACK, JA
    JOURNAL OF VIROLOGY, 1994, 68 (06) : 3478 - 3485
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGEN AND CULTURE ASSAYS
    JACKSON, JB
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (03) : 249 - 253
  • [4] DYNAMICS OF MOLECULAR-PARAMETERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VIVO
    BAGNARELLI, P
    VALENZA, A
    MENZO, S
    MANZIN, A
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    JOURNAL OF VIROLOGY, 1994, 68 (04) : 2495 - 2502
  • [5] IN-VIVO PATHOGENIC PROPERTIES OF 2 CLONAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    JAMIESON, BD
    PANG, S
    ALDROVANDI, GM
    ZHA, JL
    ZACK, JA
    JOURNAL OF VIROLOGY, 1995, 69 (10) : 6259 - 6264
  • [6] CIRCULARIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (12) : 6942 - 6952
  • [7] INTEGRATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) : 4164 - 4168
  • [8] CONSERVATION OF AN INTACT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF GENE IN-VITRO AND IN-VIVO
    SOVA, P
    VANRANST, M
    GUPTA, P
    BALACHANDRAN, R
    CHAO, W
    ITESCU, S
    MCKINLEY, G
    VOLSKY, DJ
    JOURNAL OF VIROLOGY, 1995, 69 (04) : 2557 - 2564
  • [9] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF GENE-SEQUENCES PRESENT IN-VIVO
    SHUGARS, DC
    SMITH, MS
    GLUECK, DH
    NANTERMET, PV
    SEILLIERMOISEIWITSCH, F
    SWANSTROM, R
    JOURNAL OF VIROLOGY, 1993, 67 (08) : 4639 - 4650
  • [10] 2-LTR CIRCULAR VIRAL-DNA AS A MARKER FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN-VIVO
    PAUZA, CD
    TRIVEDI, P
    MCKECHNIE, TS
    RICHMAN, DD
    GRAZIANO, FM
    VIROLOGY, 1994, 205 (02) : 470 - 478